spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

LogiPharma Europe 2018

LogiPharma Europe 2018

10-12 April 2018
Montreux Music & Convention Centre

Now in its 18th successful year, LogiPharma is the largest global end-to-end supply chain event for pharma supply chain leaders, their teams and service partners.

Download the agenda to find out exactly who is speaking, what the hottest topics are and how LogiPharma can benefit you: http://bit.ly/2mqjQGR

With representation from 18 of the top 20 pharmaceutical companies, bringing together 120 top-level pharma speakers and 700+ highly-engaged attendees across 80 bespoke presentations and small-group formats, this is the place for supply chain, pharma professionals.

As a proud partner of the event, we are pleased to offer you an exclusive 15% discount off the full price to attend, using our code: LPPMPS2018

Book your place online here: http://bit.ly/2mhwYgC

phone 44 (0) 20 7368 9854
email logipharma@wbr.co.uk
web bit.ly/2mhwYgC
email Montreux Music & Convention Centre, Switzerland
 
Print this page
Send to a friend
   
spacer
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence and Post Translational Modifications of a Monoclonal Antibody

RSSL

Monoclonal antibodies are an important class of biopharmaceuticals. They are expressed from living cells and therefore, are subject to complex biochemical pathways. Not all of these pathways are fully understood and many are known to be sensitive to subtle environmental changes during production. These changes may affect the final biopharmaceutical sequence, structure and post-translational modifications. This is in addition to any changes that may occur during subsequent purification. This means that the final product from one batch may be subtly different from another batch. Furthermore, each batch is a heterogeneous mix of similar molecules. Analysis of the degree of batch-tobatch variation, and batch heterogeneity, is therefore, very important to establish in order to be confident that the drug is safe and effective for medicinal use.
More info >>


News and Press Releases

Discussing developments on Highly Potent APIs with industry expert, Richard Arnett for the HPAPI USA conference 2019

Ahead of the 2019 HPAPI USA Conference taking place in Boston on 21st 22nd October, SMi caught up with Richard Arnett, Manager, Industrial Hygiene, Pharmascience who is speaking on Day Two of the agenda. Richard shared his thoughts on how the industry has developed and briefly touched on what he will be discussing in October.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement